Dec 6, 2007 APATECH WINS BUSINESS INITIATIVE OF THE YEAR AWARD AT ‘THES’
ApaTech, a global leader in synthetic bone graft technologies, has won the Business Initiative Award at The Times Higher Education Supplement awards (‘THES’), recognizing the success of the Company’s commercial development, based on the rapidly accelerating sales of Actifuse, its unique bone grafting material. The award was announced on 29th November at The Grosvenor House Hotel in London, and is the 3rd major accolade for ApaTech in the past 3 months.
In September 2007 ApaTech was recognized as the fastest growing UK medical technology company when it was ranked 13th in the ‘The Sunday Times Microsoft Tech Track 100’. At the ensuing Tech Track awards dinner in November 2007 ApaTech was runner up in the Research and Development Award category, a notable achievement given the depth and breadth of science underpinning Britain’s fastest growing technology companies. These accolades follow ApaTech’s appearance in the Financial Times in August 2007, when it was ranked 9th in a UBS study of the UK’s fastest growing venture capital backed companies.
The THES award recognises the practical application of research from the Interdisciplinary Research Centre in Biomedical Materials at Queen Mary, University of London. This work, to design the optimum structure and chemistry of bone substitute materials, led to the development of ActifuseTM, the unique silicate substituted bone graft product. ApaTech now commercialises its products in 20 countries worldwide in a wide range of orthopaedic and spine surgery applications.
Commenting on today’s announcement, Simon Cartmell, Chief Executive Officer of ApaTech said: “This is a remarkable achievement given the breadth of research from all of the competing academic centres and companies at these awards. Our success is solidly based on technology leadership derived from the strong underlying science that is part of our heritage. Everyone involved with ApaTech is delighted to be part of this success story and very proud to be recognised, along with Queen Mary, University of London, by The Times Higher awards.”
In September 2007 ApaTech was recognized as the fastest growing UK medical technology company when it was ranked 13th in the ‘The Sunday Times Microsoft Tech Track 100’. At the ensuing Tech Track awards dinner in November 2007 ApaTech was runner up in the Research and Development Award category, a notable achievement given the depth and breadth of science underpinning Britain’s fastest growing technology companies. These accolades follow ApaTech’s appearance in the Financial Times in August 2007, when it was ranked 9th in a UBS study of the UK’s fastest growing venture capital backed companies.
The THES award recognises the practical application of research from the Interdisciplinary Research Centre in Biomedical Materials at Queen Mary, University of London. This work, to design the optimum structure and chemistry of bone substitute materials, led to the development of ActifuseTM, the unique silicate substituted bone graft product. ApaTech now commercialises its products in 20 countries worldwide in a wide range of orthopaedic and spine surgery applications.
Commenting on today’s announcement, Simon Cartmell, Chief Executive Officer of ApaTech said: “This is a remarkable achievement given the breadth of research from all of the competing academic centres and companies at these awards. Our success is solidly based on technology leadership derived from the strong underlying science that is part of our heritage. Everyone involved with ApaTech is delighted to be part of this success story and very proud to be recognised, along with Queen Mary, University of London, by The Times Higher awards.”
